Predictive markers in breast cancer: An update on ER and HER2 testing and reporting

Seminars in Diagnostic Pathology
Benjamin C Calhoun, Laura C Collins

Abstract

Gene expression profiling of human tumors has provided a new paradigm for classifying breast carcinomas, predicting response to treatment, and risk of recurrence. Estrogen receptor (ER), human epidermal growth factor 2 (HER2) receptor, and proliferation-related genes are the main drivers of classification in many of the gene expression profiling tests for breast cancer. However, ER, progesterone receptor (PR), and HER2 receptor status remain essential in determining the need and type of adjuvant therapy. These biomarkers are routinely tested for in all invasive breast carcinomas; ER testing is also performed on cases of ductal carcinoma in situ (DCIS). This article will provide an update on current guidelines from the American Society of Clinical Oncologists (ASCO) and the College of American Pathologists (CAP) for ER and HER2 testing by immunohistochemistry (IHC) and in situ hybridization (ISH). The populations to be tested, antibody selection, criteria for interpretation, and reporting are discussed. The molecular alterations that correlate with IHC results, alternative methods of testing, and the current approach to complex aspects of HER2 testing, including heterogeneity and polysomy, also are summarized.

References

Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Dec 20, 2002·The New England Journal of Medicine·Marc J van de VijverRené Bernards
May 4, 2004·Nature Reviews. Cancer·Andreas GschwindAxel Ullrich
Oct 21, 2005·The New England Journal of Medicine·Martine J Piccart-GebhartUNKNOWN Herceptin Adjuvant (HERA) Trial Study Team
Oct 21, 2005·The New England Journal of Medicine·Edward H RomondNorman Wolmark
Dec 22, 2005·Journal of the National Cancer Institute·Anthony McCabeDavid L Rimm
Nov 10, 2006·Clinical Breast Cancer·Joseph A Sparano
Nov 23, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maggie C U CheangAllen M Gown
Mar 28, 2008·The New England Journal of Medicine·Soonmyung PaikNorman Wolmark
May 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D Craig Allred
Jan 7, 2009·Genetics in Medicine : Official Journal of the American College of Medical Genetics·UNKNOWN Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Dec 1, 2007·Molecular Oncology·Fatima CardosoUNKNOWN TRANSBIG Consortium
Jun 29, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GoldhirschUNKNOWN Panel members
Oct 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David J DabbsRohit Bhargava
Nov 2, 2011·The Breast : Official Journal of the European Society of Mastology·Kamal S SainiMartine Piccart
Feb 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Takayuki IwamotoLajos Pusztai
Feb 4, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·James A KrausRohit Bhargava
Nov 13, 2012·Journal of the American College of Surgeons·Lauren T GreerLorraine Tafra
Nov 20, 2012·American Journal of Clinical Pathology·David A CohenRohit Bhargava
Nov 21, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S GuiuJ S Reis-Filho
Jan 23, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H A AzimC Swanton
Jun 29, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Wedad M HannaGiuseppe Viale
Jul 3, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mitch DowsettJack Cuzick
Aug 7, 2013·Hematology/oncology Clinics of North America·Mark D Pegram
Aug 7, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GoldhirschUNKNOWN Panel members
Oct 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio C WolffUNKNOWN College of American Pathologists
Nov 23, 2013·Journal of the National Cancer Institute·Katherine L Pogue-GeileSoonmyung Paik
Apr 10, 2014·American Journal of Clinical Pathology·Nika C GloyeskeRohit Bhargava

❮ Previous
Next ❯

Citations

Nov 12, 2015·Thoracic Cancer·Hongwei GuoJian Zhang
May 5, 2017·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Róbert PaulikBéla Molnár
Dec 5, 2018·Expert Opinion on Investigational Drugs·Anna La SalviaRocio Garcia-Carbonero
Jul 18, 2017·Archives of Pathology & Laboratory Medicine·Megan L TroxellKristin C Jensen
Mar 21, 2017·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·B M Turner, D G Hicks
Jul 5, 2016·Alcoholism, Clinical and Experimental Research·Catina Crismale-GannWendie S Cohick
Apr 23, 2020·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Youran ZouSarah Chiang
Dec 15, 2018·Journal of Cellular Physiology·Ehsan GharibMohammad Reza Zali
Jan 25, 2019·Oncology Letters·Lifeng YuMinjie Wei
Aug 28, 2020·International Journal of Molecular Sciences·Tung-Yi LinTai-Long Pan
Jan 27, 2017·Oncology Letters·Luciana Marques PaulaRenata De Azevedo Canevari
Mar 3, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Deborah B DoroshowRoy S Herbst
Feb 3, 2021·Reproduction in Domestic Animals = Zuchthygiene·Ana Carina Heil da Silva MatosJuliana da Silva Leite
Mar 26, 2020·Translational Oncology·Lorenza MittempergherUNKNOWN Annuska M Glas. Electronic address: Annuska.Glas@agendia.com

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.